Adriana Plesa
Research Subjects
Research Interests
Adriana Plesa has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Anca Botezatu
Molecular Virology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, 030304 Bucharest, Romania
7 shared publications - Gabriela Anton
Stefan S. Nicolau Institute of Virology, Romanian Academy, 030304 Bucharest, Romania
5 shared publications Demetra Socolov
3 shared publicationsGabriela Anton
3 shared publicationsIrina Huica
3 shared publicationsIrina Huică
3 shared publications
Latest Publications
- Open Access
- 30 April 2019
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 13 (04) , 326-333
High-risk human papillomaviruses distribution in Romanian women with negative cytology
Introduction: Romania has the highest incidence and mortality rate of cervical cancer in Europe. The objective was to estimate the prevalence of high-risk human papillomavirus (hrHPV) genotypes and to evaluate the role of certain socio-behavioral factors in acquiring viral infection, in a cohort of Romanian women with negative Pap. Methodology: In a prevalence study 611 women (aged 17-58 years) with negative Pap, with no known history of atypical cytology and valid HPV test were included. Each participant completed a questionnaire containing data on socio-behavioral factors. From 344 women aged between 30-58 years, 63 were randomly selected for a second examination (conventional cytology and HPV detection and genotyping) after twelve months. Results: Of the 611 women, 19.80% were HPV positive, 14.73% infected with hrHPV. Differences in the prevalence of hrHPV (17.60% versus 12.50%) as single (13.01% vs 9.01%) and multiple infections (9.71% vs 3.49%) were noted between women under the age of 30 and above. Among socio-behavioral factors, marital status and multiple sexual partners correlate with HPV and hrHPV infection. At follow-up, from 34 HPV negative cases, 10 changed to positive (5 hrHPV), while 2 developed abnormal cytology. Out of the 29 HPV positive cases, 12 cleared the HPV infection and 17 retested positive of which 4 worsened their cytology. Conclusions: In Romania, HPV infection is common in women with negative cytology. HPV genotyping is of epidemiological importance because the distribution of hrHPV types can determine the impact of prophylactic vaccines and the necessity of HPV testing as screening method.
- 30 April 2019
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 13 (04) , 326-333
Open AccessHigh-risk human papillomaviruses distribution in Romanian women with negative cytology
Introduction: Romania has the highest incidence and mortality rate of cervical cancer in Europe. The objective was to estimate the prevalence of high-risk human papillomavirus (hrHPV) genotypes and to evaluate the role of certain socio-behavioral factors in acquiring viral infection, in a cohort of Romanian women with negative Pap. Methodology: In a prevalence study 611 women (aged 17-58 years) with negative Pap, with no known history of atypical cytology and valid HPV test were included. Each participant completed a questionnaire containing data on socio-behavioral factors. From 344 women aged between 30-58 years, 63 were randomly selected for a second examination (conventional cytology and HPV detection and genotyping) after twelve months. Results: Of the 611 women, 19.80% were HPV positive, 14.73% infected with hrHPV. Differences in the prevalence of hrHPV (17.60% versus 12.50%) as single (13.01% vs 9.01%) and multiple infections (9.71% vs 3.49%) were noted between women under the age of 30 and above. Among socio-behavioral factors, marital status and multiple sexual partners correlate with HPV and hrHPV infection. At follow-up, from 34 HPV negative cases, 10 changed to positive (5 hrHPV), while 2 developed abnormal cytology. Out of the 29 HPV positive cases, 12 cleared the HPV infection and 17 retested positive of which 4 worsened their cytology. Conclusions: In Romania, HPV infection is common in women with negative cytology. HPV genotyping is of epidemiological importance because the distribution of hrHPV types can determine the impact of prophylactic vaccines and the necessity of HPV testing as screening method.
- Open Access
- 13 July 2016
- Published by IntechOpen
The Involvement of Epigenetic Mechanisms in HPV‐Induced Cervical Cancer
The Involvement of Epigenetic Mechanisms in HPV‐Induced Cervical Cancer | InTechOpen, Published on: 2016-07-13. Authors: Adriana Plesa, Iulia V. Iancu, Anca Botezatu, et
- 13 July 2016
- Published by IntechOpen
Open AccessThe Involvement of Epigenetic Mechanisms in HPV‐Induced Cervical Cancer
The Involvement of Epigenetic Mechanisms in HPV‐Induced Cervical Cancer | InTechOpen, Published on: 2016-07-13. Authors: Adriana Plesa, Iulia V. Iancu, Anca Botezatu, et
- 6 January 2016
- Vol. 74, 33-9
E5HPV16 mRNA EXPRESSION PATTERN ANALYSIS IN PATIENTS WITH CERVICAL LESIONS IN VIRAL STATUS CONTEXT.
Human papilloma virus (HPV) may cause mostly transient infections of cutaneous and mucous epithelia. Persistent HPV genital infections may induce pre-malignant or malignant lesions. While E6 and E7 HPV genes' malignant character is known, E5 is still under debate. We evaluated the possible role of E5 gene in cervix oncogenesis, in patients with abnormal cytology and HPV1 6 positive, in the context of viral status correlated with potential targets (p21, EGFR). HPV DNA was detected and genotyped using Linear Array HPV Genotyping Test (Roche Molecular Biochemicals, Mannheim, Germany) and E2, E6, E5 HPV16, p21 and EGFR transcripts levels were investigated by qRT-PCR. Our results indicate a significantly high E5 expression in low grade cytology, expression correlated with a moderated E6 and low p21 levels. All HSIL specimens presented integrated/mixed viral forms; mixed forms presented moderate E5 expression, high levels of p21 correlates with E6 oncogene high expression. These findings indicate a potential role for E5 pattern of expression in discriminating be-tween lesions that may progress to cancer.
- 6 January 2016
- Vol. 74, 33-9
E5HPV16 mRNA EXPRESSION PATTERN ANALYSIS IN PATIENTS WITH CERVICAL LESIONS IN VIRAL STATUS CONTEXT.
Human papilloma virus (HPV) may cause mostly transient infections of cutaneous and mucous epithelia. Persistent HPV genital infections may induce pre-malignant or malignant lesions. While E6 and E7 HPV genes' malignant character is known, E5 is still under debate. We evaluated the possible role of E5 gene in cervix oncogenesis, in patients with abnormal cytology and HPV1 6 positive, in the context of viral status correlated with potential targets (p21, EGFR). HPV DNA was detected and genotyped using Linear Array HPV Genotyping Test (Roche Molecular Biochemicals, Mannheim, Germany) and E2, E6, E5 HPV16, p21 and EGFR transcripts levels were investigated by qRT-PCR. Our results indicate a significantly high E5 expression in low grade cytology, expression correlated with a moderated E6 and low p21 levels. All HSIL specimens presented integrated/mixed viral forms; mixed forms presented moderate E5 expression, high levels of p21 correlates with E6 oncogene high expression. These findings indicate a potential role for E5 pattern of expression in discriminating be-tween lesions that may progress to cancer.
- 1 January 2016
- Published by Celsius Publishing House in Journal of Translational Medicine and Research
- Vol. 21 (4) , 259
S100A4 and ERBB2 as Co-Factors in Pancreatic Cancer
- 1 January 2016
- Published by Celsius Publishing House in Journal of Translational Medicine and Research
- Vol. 21 (4) , 259
S100A4 and ERBB2 as Co-Factors in Pancreatic Cancer
- 21 August 2014
- Published by Springer Nature in Archives of Virology
- Vol. 159 (12) , 3305-3320
Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients
The aim of this study was to identify and associate the sequence variations of human Papillomavirus 16 (HPV16) genes from women who live in two different areas of Romania and associate them with malignant progression. One hundred twenty-four HPV16-positive cervical isolates were collected, and the E2, E4, E5, E6 and E7 viral genes were sequenced. Two new missense mutations in the E6 gene (C279G and A305C) were found (together or alone, in association with other mutations) in 44 of 124 cases. The most frequently simultaneously mutated genes were E4/E2 hinge, E5 and E6 (p = 0.0004) in squamous cell carcinoma (SCC) samples. Also, for SCC patients, the best-correlated mutation patterns were obtained for E4/E2 hinge-E5 (r = 0.7984; p < 0.0001). No sample was found to have all of the investigated viral genes concurrently mutated. Phylogenetic analysis was performed to characterize the viral variants. Similar results were found for SCC and cervical intraepithelial neoplasia III (CINIII) cases. After all of the target gene sequences were assembled, all patients were found to be infected with viruses of the HPV16- European-German (EG) lineage, and two clusters were identified, the first (55/96 variants) from Moldavia and the second (41/96 variants) from Bucharest. The distinct cluster derived from EG in Moldavia could partially explain the increased frequency of SCC in this area. This study has generated a comprehensive set of sequence variation data on HPV16 circulating in Romania to join the existing data and highlight the important role of HPV16 variants during cervical carcinogenesis.
- 21 August 2014
- Published by Springer Nature in Archives of Virology
- Vol. 159 (12) , 3305-3320
Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients
The aim of this study was to identify and associate the sequence variations of human Papillomavirus 16 (HPV16) genes from women who live in two different areas of Romania and associate them with malignant progression. One hundred twenty-four HPV16-positive cervical isolates were collected, and the E2, E4, E5, E6 and E7 viral genes were sequenced. Two new missense mutations in the E6 gene (C279G and A305C) were found (together or alone, in association with other mutations) in 44 of 124 cases. The most frequently simultaneously mutated genes were E4/E2 hinge, E5 and E6 (p = 0.0004) in squamous cell carcinoma (SCC) samples. Also, for SCC patients, the best-correlated mutation patterns were obtained for E4/E2 hinge-E5 (r = 0.7984; p < 0.0001). No sample was found to have all of the investigated viral genes concurrently mutated. Phylogenetic analysis was performed to characterize the viral variants. Similar results were found for SCC and cervical intraepithelial neoplasia III (CINIII) cases. After all of the target gene sequences were assembled, all patients were found to be infected with viruses of the HPV16- European-German (EG) lineage, and two clusters were identified, the first (55/96 variants) from Moldavia and the second (41/96 variants) from Bucharest. The distinct cluster derived from EG in Moldavia could partially explain the increased frequency of SCC in this area. This study has generated a comprehensive set of sequence variation data on HPV16 circulating in Romania to join the existing data and highlight the important role of HPV16 variants during cervical carcinogenesis.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
Methylation status of HOXB4 gene in papillary thyroid carcinoma
Introduction: HOXB4 functions as a transcription factor involved in cell differentiation during embryogenesis and plays a role in apoptosis. Aim: This study analyzed HOXB4 methylation status in thyroid papillary carcinoma. Method: 54 patients aged 10–82 years hospitalized for thyroidectomy were included between January 2013 and July 2013. The inclusion criterion was patients with thyroid nodules with indication for surgery and the exclusion criteria were: hyperthyroidism, medullary thyroid carcinoma, thyroid metastasis, other thyroid tumors, and anaplastic thyroid carcinoma. Patients were divided into four groups: Group 1: 26 subjects with papillary thyroid carcinoma, Group 2: 14 patients with follicular adenoma, Group 3: nine patients with multinodular goiter and Group 4: three patients with autoimmune thyroiditis. Methylation status of HOXB4 gene was assessed from normal thyroid tissue and tumoral tissue (thyroid carcinoma, follicular adenoma, multinodular goiter, and autoimmune thyroiditis) from the same patient. Total DNA was isolated from tissues and was treated with sodium bisulfite (EpiTect Bisulfite, and Qiagen) and was amplified using Direct Q-MSP. SPSS 18 (2010) program was used to perform statistical analyze. Results were compared using Kruskal–Wallis and Mann–Whitney U tests and were considered statistical relevant if PP=0.0097). The level of methylation of HOXB4 gene in tumor tissue is higher in papillary thyroid carcinoma than the follicular adenoma (P<0.05). Conclusion: Analysis of the methylation status of HOXB4 gene showed a level of methylation significantly different between tumor and peritumoral tissue for the pathology investigated. Acknowledgement: Results are part of the research project PCCA2 nr. 135/2012.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
Methylation status of HOXB4 gene in papillary thyroid carcinoma
Introduction: HOXB4 functions as a transcription factor involved in cell differentiation during embryogenesis and plays a role in apoptosis. Aim: This study analyzed HOXB4 methylation status in thyroid papillary carcinoma. Method: 54 patients aged 10–82 years hospitalized for thyroidectomy were included between January 2013 and July 2013. The inclusion criterion was patients with thyroid nodules with indication for surgery and the exclusion criteria were: hyperthyroidism, medullary thyroid carcinoma, thyroid metastasis, other thyroid tumors, and anaplastic thyroid carcinoma. Patients were divided into four groups: Group 1: 26 subjects with papillary thyroid carcinoma, Group 2: 14 patients with follicular adenoma, Group 3: nine patients with multinodular goiter and Group 4: three patients with autoimmune thyroiditis. Methylation status of HOXB4 gene was assessed from normal thyroid tissue and tumoral tissue (thyroid carcinoma, follicular adenoma, multinodular goiter, and autoimmune thyroiditis) from the same patient. Total DNA was isolated from tissues and was treated with sodium bisulfite (EpiTect Bisulfite, and Qiagen) and was amplified using Direct Q-MSP. SPSS 18 (2010) program was used to perform statistical analyze. Results were compared using Kruskal–Wallis and Mann–Whitney U tests and were considered statistical relevant if PP=0.0097). The level of methylation of HOXB4 gene in tumor tissue is higher in papillary thyroid carcinoma than the follicular adenoma (P<0.05). Conclusion: Analysis of the methylation status of HOXB4 gene showed a level of methylation significantly different between tumor and peritumoral tissue for the pathology investigated. Acknowledgement: Results are part of the research project PCCA2 nr. 135/2012.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
DNMT1 expression in papillary thyroid carcinoma
Introduction: In human cancer cells DNMTs are responsible for both de novo and maintenance methylation of tumor suppressor genes. Many studies have analyzed the relationship between the altered expression of DNMT1 and DNA methylation in cancer. Aim: To analyze DNMT1 expression in thyroid papillary carcinoma. Design: 49 patients aged 10–82 years hospitalized for thyroidectomy were included between January 2013 and July 2013. The inclusion criterion was patients with thyroid nodules with indication for surgery and the exclusion criteria were: hyperthyroidism, medullary thyroid carcinoma, thyroid metastasis, other thyroid tumors, and anaplastic thyroid carcinoma. Patients were divided into three groups. Group 1: 26 subjects with papillary thyroid carcinoma. Group 2: 14 patients with follicular adenoma. Group 3: nine patients with multinodular goiter. Group 1 was divided in: Group 1.1- classical variant of papillary thyroid carcinoma, Group 1.2 follicular variant of papillary carcinoma; Group 1.3 diffuse sclerosing variant of papillary carcinoma. Total RNA was isolated from tissues and reverse transcribed. DNMT1 expression levels were investigated by qRT-PCR using Taqman (Applied Biosystem). Double normalization was performed related to gene expression levels found in peritumoral tissues. SPSS 18 (2010) program was used to perform statistical analyze. Results were compared using Kruskal–Wallis and Mann–Whitney U tests and were considered statistical relevant if PP>0.05). The comparison of cancer subtypes did not reveal significant differences for DNMT1. DNMT1 expression did not correlate with tumor stage, tumor multifocality, capsular, vascular or lymphatic invasion or with metastasis. Conclusion: DNMT1 is not overexpressed in papillary thyroid carcinoma and does not correlate with tumor stage, tumor multifocality, capsular, vascular or lymphatic invasion or with metastasis. Acknowledgements: Results are part of the research project PCCA2 nr. 135/2012.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
DNMT1 expression in papillary thyroid carcinoma
Introduction: In human cancer cells DNMTs are responsible for both de novo and maintenance methylation of tumor suppressor genes. Many studies have analyzed the relationship between the altered expression of DNMT1 and DNA methylation in cancer. Aim: To analyze DNMT1 expression in thyroid papillary carcinoma. Design: 49 patients aged 10–82 years hospitalized for thyroidectomy were included between January 2013 and July 2013. The inclusion criterion was patients with thyroid nodules with indication for surgery and the exclusion criteria were: hyperthyroidism, medullary thyroid carcinoma, thyroid metastasis, other thyroid tumors, and anaplastic thyroid carcinoma. Patients were divided into three groups. Group 1: 26 subjects with papillary thyroid carcinoma. Group 2: 14 patients with follicular adenoma. Group 3: nine patients with multinodular goiter. Group 1 was divided in: Group 1.1- classical variant of papillary thyroid carcinoma, Group 1.2 follicular variant of papillary carcinoma; Group 1.3 diffuse sclerosing variant of papillary carcinoma. Total RNA was isolated from tissues and reverse transcribed. DNMT1 expression levels were investigated by qRT-PCR using Taqman (Applied Biosystem). Double normalization was performed related to gene expression levels found in peritumoral tissues. SPSS 18 (2010) program was used to perform statistical analyze. Results were compared using Kruskal–Wallis and Mann–Whitney U tests and were considered statistical relevant if PP>0.05). The comparison of cancer subtypes did not reveal significant differences for DNMT1. DNMT1 expression did not correlate with tumor stage, tumor multifocality, capsular, vascular or lymphatic invasion or with metastasis. Conclusion: DNMT1 is not overexpressed in papillary thyroid carcinoma and does not correlate with tumor stage, tumor multifocality, capsular, vascular or lymphatic invasion or with metastasis. Acknowledgements: Results are part of the research project PCCA2 nr. 135/2012.
- 2 July 2011
- Vol. 70 (1) , 5-10
Mitochondrial DNA mutations in patients with HRHPV-related cervical lesions.
High risk human papillomaviruses (hr-HPV) are known to be the etiological agents of cervical cancer disease. On the other hand, other cofactors are considered to be important in cervix carcinogenesis. Mutations in mitochondrial DNA (mtDNA) as well as alterations in mtDNA content have been reported in numerous cancers examined to date. The D-loop region has been shown to be a mutational "hot spot" in human cancer. In order to evaluate the role of mtDNA mutations in cervical lesions progression, cervical specimens (from 79 women, 29-65 years old) were investigated. DNA was isolated (High Pure PCR Template, Roche Diagnostics) from cervical cells from patients with different cytology (normal cervical epithelium, ASCUS-Atypical Squamous Cells of Undetermined Significance, LGSIL-Low-Grade Intraepithelial Lesion, HGSIL-High-Grade Intraepithelial Lesion and SCC-Squamous Cell Carcinoma) and tested for HPV DNA presence (Linear Array HPV Genotyping Test, Roche Diagnostics). To elucidate a causative role of mtDNA in cervical lesions, mtDNA mutations were investigated using Mutector mtDNA kit (TrimGen Corporation). In patients with normal and ASCUS cytology, mtDNA mutations were absent. 16.66% of LGSIL patients presented mutations in D-loop region whereas 28.57% HGSIL cases showed mutations in mtDNA. Mutations were detected in 66.66% cases of SCC cases. These studies provide strong evidence that instability in the D-loop region of mtDNA may be involved in cervical dysplasia. We suggested that mtDNA mutations may play a role in cervical precursor lesions and cancer but their role in the mechanism of carcinogenesis remains to be solved.
- 2 July 2011
- Vol. 70 (1) , 5-10
Mitochondrial DNA mutations in patients with HRHPV-related cervical lesions.
High risk human papillomaviruses (hr-HPV) are known to be the etiological agents of cervical cancer disease. On the other hand, other cofactors are considered to be important in cervix carcinogenesis. Mutations in mitochondrial DNA (mtDNA) as well as alterations in mtDNA content have been reported in numerous cancers examined to date. The D-loop region has been shown to be a mutational "hot spot" in human cancer. In order to evaluate the role of mtDNA mutations in cervical lesions progression, cervical specimens (from 79 women, 29-65 years old) were investigated. DNA was isolated (High Pure PCR Template, Roche Diagnostics) from cervical cells from patients with different cytology (normal cervical epithelium, ASCUS-Atypical Squamous Cells of Undetermined Significance, LGSIL-Low-Grade Intraepithelial Lesion, HGSIL-High-Grade Intraepithelial Lesion and SCC-Squamous Cell Carcinoma) and tested for HPV DNA presence (Linear Array HPV Genotyping Test, Roche Diagnostics). To elucidate a causative role of mtDNA in cervical lesions, mtDNA mutations were investigated using Mutector mtDNA kit (TrimGen Corporation). In patients with normal and ASCUS cytology, mtDNA mutations were absent. 16.66% of LGSIL patients presented mutations in D-loop region whereas 28.57% HGSIL cases showed mutations in mtDNA. Mutations were detected in 66.66% cases of SCC cases. These studies provide strong evidence that instability in the D-loop region of mtDNA may be involved in cervical dysplasia. We suggested that mtDNA mutations may play a role in cervical precursor lesions and cancer but their role in the mechanism of carcinogenesis remains to be solved.
- 26 March 2011
- Vol. 69 (3) , 113-8
TGF-beta signalling pathway factors in HPV-induced cervical lesions.
Human papillomaviruses (HPV) are considered the etiological agents of cervical cancer, especially high-risk genotypes. TGF-beta (transforming growth factor-beta) is well known for its anti-proliferative effects but the neoplastic cells often lose their sensitivity to TGF-beta. A characteristic alteration associated with malignant progression is the loss of responsiveness to TGF-beta1-induced cell growth inhibition. The aim of the present study was to establish the possible role of some members of TGF-beta signalling pathway during cervical cancer development and the possible relationship with HPV infection. In order to establish TGF-beta gene expression levels in cervical oncogenesis, TGF-beta1, TGF-beta1 receptors and Smad2 were investigated in precancerous and cervical cancer samples (Quantitative Real-Time PCR). The study revealed that 84.5% of patients were positive for HPV DNA. The most prevalent HPV genotypes were high-risk HPV 16 and 18 in single or co-infections. Expression of TGF-beta1 decreased as tumor cells progressed from cervical intraepithelial neoplasia to cervical carcinoma. Furthermore, we observed that cervical lesions without HPV infection expressed significantly less TGF-beta1. TGF-betaRI and Smad2 gene expression levels were found to be decreased in SCC and AC samples in contrast with CIN1 and CIN2/3 samples. Our results showed that in human cervical cancer the disruption of TGF-beta/Smad signalling pathway might contribute to the malignant progression of cervical dysplasia. These data emphasize the importance of canonical TGF-beta pathway integrity in carcinogenesis.
- 26 March 2011
- Vol. 69 (3) , 113-8
TGF-beta signalling pathway factors in HPV-induced cervical lesions.
Human papillomaviruses (HPV) are considered the etiological agents of cervical cancer, especially high-risk genotypes. TGF-beta (transforming growth factor-beta) is well known for its anti-proliferative effects but the neoplastic cells often lose their sensitivity to TGF-beta. A characteristic alteration associated with malignant progression is the loss of responsiveness to TGF-beta1-induced cell growth inhibition. The aim of the present study was to establish the possible role of some members of TGF-beta signalling pathway during cervical cancer development and the possible relationship with HPV infection. In order to establish TGF-beta gene expression levels in cervical oncogenesis, TGF-beta1, TGF-beta1 receptors and Smad2 were investigated in precancerous and cervical cancer samples (Quantitative Real-Time PCR). The study revealed that 84.5% of patients were positive for HPV DNA. The most prevalent HPV genotypes were high-risk HPV 16 and 18 in single or co-infections. Expression of TGF-beta1 decreased as tumor cells progressed from cervical intraepithelial neoplasia to cervical carcinoma. Furthermore, we observed that cervical lesions without HPV infection expressed significantly less TGF-beta1. TGF-betaRI and Smad2 gene expression levels were found to be decreased in SCC and AC samples in contrast with CIN1 and CIN2/3 samples. Our results showed that in human cervical cancer the disruption of TGF-beta/Smad signalling pathway might contribute to the malignant progression of cervical dysplasia. These data emphasize the importance of canonical TGF-beta pathway integrity in carcinogenesis.